NCT04467931: ACEI or ARB and COVID-19 Severity and Mortality in US Veterans |
|
|
| Completed | N/A | 22213 | US | ACEI/ARB, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril, azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan, Non-ACEI/ARB, doxazosin, prazosin, terazosin, acebutolol, nebivolol, atenolol, betaxolol, bisoprolol, metoprolol, pindolol, penbutolol, carvedilol, labetalol, nadolol, propranolol, timolol, amlodipine, felodipine, isradipine, nifedipine, nicardipine, nisoldipine, diltiazem, verapamil, clonidine, guanfacine, guanabenz, methyldopa, reserpine, hydralazine, minoxidil, aliskiren, spironolactone, eplerenone, bumetanide, furosemide, ethacrynic acid, torsemide, amiloride, triamterene, bendroflumethiazide, chlorothiazide, chlorthalidone, hydrochlorothiazide, indapamide, metolazone, ACEI, ARB | University of Utah, VA Salt Lake City Health Care System, University of Pennsylvania, Wake Forest University Health Sciences, University of Florida, Johns Hopkins Bloomberg School of Public Health, Boston University, Northwestern University, Edith Nourse Rogers Memorial Veterans Hospital, Columbia University, MedStar Georgetown University Hospital | Hypertension, COVID | 10/20 | 12/20 | | |